Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe thigh is one of three licensed injection sites for tirzepatide, alongside the abdomen and upper arm. It works well for many people — the outer thigh offers a reasonably large, accessible area of subcutaneous fat — and the NHS medicines page for tirzepatide confirms all three sites are suitable. Tirzepatide (sold in the UK as Mounjaro) is a prescription-only medicine; a GPhC-registered prescriber assesses clinical suitability before treatment starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The target zone is the front or outer thigh, not the inner thigh, where the skin is thinner and large blood vessels sit closer to the surface. Aim for the middle third of the thigh: roughly midway between your knee and your hip. That area typically has a good layer of subcutaneous fat, which is where tirzepatide needs to be delivered.
Sit down with your leg relaxed before you inject. A tense muscle makes the injection harder and slightly more uncomfortable. If your thighs are quite lean, pinch a small fold of skin gently between your fingers before pressing the KwikPen in, this creates a little distance between the skin surface and the muscle beneath.
For a full walkthrough of the injection steps specific to this site, the step-by-step guide to giving a tirzepatide injection in the thigh covers the process in detail. The Patient Information Leaflet inside every Mounjaro box also includes illustrated guidance, read it at least once even if you feel confident.
A question our prescribers hear most weeks: does rotating between left and right count as proper site rotation? The short answer is no, not on its own. Rotating between left and right thigh helps a little, but the bigger benefit comes from moving between the three licensed sites altogether (thigh, abdomen, upper arm) over successive weeks.
Repeated injections into the same small area of skin can cause lipohypertrophy, a localised build-up of fatty tissue that feels firm or lumpy. Beyond the cosmetic aspect, it matters clinically: tirzepatide absorbed through changed skin tissue may not reach the bloodstream as predictably, which could affect how well the medicine works. A simple rotation pattern (thigh one week, abdomen the next, upper arm the week after) keeps any one spot from bearing the load every time.
If you prefer the thigh and want to use it more often, at least move around within the thigh itself: left outer thigh, then right outer thigh, varying the spot by a few centimetres each time. Never inject into skin that is red, bruised, or tender from a previous injection. More on the broader rotation principles is covered in the guide to where exactly to inject tirzepatide in the thigh.
Injection-site reactions are among the most commonly reported effects of subcutaneous GLP-1 medicines. At the thigh these typically show up as mild redness, slight swelling, itching, or a small firm patch in the hours after injecting. Most settle within a day or two without any treatment needed.
Cleaning the skin beforehand with a fresh alcohol swab and letting it dry completely before injecting reduces the risk of irritation. Injecting cold medicine straight from the fridge can also cause more discomfort, leaving the pen at room temperature for 30 minutes before use often makes the injection noticeably gentler. Always check the Mounjaro SmPC for the permitted room-temperature window rather than guessing.
If you notice a persistent lump that does not resolve after a couple of weeks, skin dimpling, or any sign of infection (spreading redness, warmth, or discharge), contact your prescriber promptly. The MHRA's Yellow Card scheme is also there for reporting unexpected or serious reactions.
The broader side-effect picture for tirzepatide is predominantly gastrointestinal (nausea, constipation, indigestion) rather than site-specific. For a fuller picture of what to expect and how to manage it, the tirzepatide injection guide runs through the most common experiences week by week.
There is no head-to-head clinical evidence showing that tirzepatide is absorbed significantly differently between the three licensed sites in the way that has been demonstrated for some older insulins. All three are considered equivalent for practical purposes in the prescribing guidance. The best site is the one you can access comfortably, inject accurately, and rotate away from the following week.
In practice, the abdomen is often the easiest to reach and tends to have more subcutaneous fat for most people, which is why it is frequently the default. The thigh is popular with people who find it easier to see what they are doing when seated, or who want to avoid the abdomen for personal reasons, and our dedicated page on the Mounjaro thigh injection site goes into further detail for anyone who plans to use this location regularly. The upper arm requires a bit more coordination unless someone else helps. All three are equally valid.
If you are thinking about starting Mounjaro and wondering about the practicalities of self-injecting, those questions are worth raising at consultation, a prescriber can talk through your individual circumstances. Cost is another practical question; the Mounjaro pricing page sets out what private treatment involves.
Tirzepatide is a prescription-only medicine and clinical suitability is assessed before every prescription is issued. If you are ready to explore whether it is appropriate for you, start your free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.